Avgerinos A, Axarlis S, Dragatsis J, Karidas T, Malamataris S
Military Pharmaceutical Laboratories, Athens, Greece.
J Chromatogr B Biomed Appl. 1995 Nov 3;673(1):142-6. doi: 10.1016/0378-4347(95)00248-h.
A simple and rapid (extractionless) high-performance liquid chromatographic method with UV detection, at 330 nm, was developed for the simultaneous determination of piroxicam and its major metabolite, 5'-hydroxypiroxicam, in human plasma and urine. Acidified plasma and alkali-treated urine samples are used and naproxen is added as internal standard. The separation is performed at 40 degrees C on a C18 Spherisorb column with acetonitrile--0.1 M sodium acetate (33:67, v/v, pH 3.3) as mobile phase. The retention time is 2.2 min for 5'-hydroxypiroxicam, 2.6 min for piroxicam and 3.2 min for naproxen. The detection limit is 0.05 micrograms/ml using a 100-microliters loop.
建立了一种简单快速(无需萃取)的高效液相色谱法,采用紫外检测,检测波长为330nm,用于同时测定人血浆和尿液中的吡罗昔康及其主要代谢物5'-羟基吡罗昔康。使用酸化血浆和碱处理尿液样本,并加入萘普生作为内标。在40℃下,以乙腈-0.1M醋酸钠(33:67,v/v,pH 3.3)为流动相,在C18 Spherisorb柱上进行分离。5'-羟基吡罗昔康的保留时间为2.2分钟,吡罗昔康为2.6分钟,萘普生为3.2分钟。使用100微升定量环时,检测限为0.05微克/毫升。